Question 1

What is the catalog number for N'-[ (2-chloroacetyl) oxy]-2- (3-cyclopropyl-2,3-dihydro-1H-imidazo[4,5-b]pyridin-2-yl) ethanimidamide?

Accepted Answer

The catalog number for N'-[ (2-chloroacetyl) oxy]-2- (3-cyclopropyl-2,3-dihydro-1H-imidazo[4,5-b]pyridin-2-yl) ethanimidamide is OR27596.

Question 2

Is N'-[ (2-chloroacetyl) oxy]-2- (3-cyclopropyl-2,3-dihydro-1H-imidazo[4,5-b]pyridin-2-yl) ethanimidamide in stock?

Accepted Answer

N'-[ (2-chloroacetyl) oxy]-2- (3-cyclopropyl-2,3-dihydro-1H-imidazo[4,5-b]pyridin-2-yl) ethanimidamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

N'-[ (2-chloroacetyl) oxy]-2- (3-cyclopropyl-2,3-dihydro-1H-imidazo[4,5-b]pyridin-2-yl) ethanimidamide

Product Specifications

CAS Number

MDL Number

Smiles

Frequently Asked Questions

Explore Other Products

CD45RB (B-Cell Marker) (N/A), CF488A conjugate, 0.1mg/mL

GP2 (Glycoprotein 2) / ZAP75 (GP2/1803), 0.2mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF647 conjugate, 0.1mg/mL

Nuclear Membrane (AE-5), CF568 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF568 conjugate, 0.1mg/mL

CD36 (Platelet & Microvessel Marker) (GPIIIb/1654), CF647 conjugate, 0.1mg/mL